Merck
June 23, 2026
Theater 2
Type: Company Presentation
Focus Area:
Multiple Therapeutics
At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com.
Company HQ City:
Rahway
Company HQ State:
NJ
Company HQ Country:
United States
Year Founded:
1891
Lead Product in Development:
Broad product portfolio and pipeline
CEO
Robert M. Davis, Chairman of the Board and Chief Executive Officer, Merck & Co., Inc.
Development Phase of Lead Product
Multiple Products in Market
Exchange
NYSE
Ticker
MRK
When you expect your next catalyst update?
Multiple Ongoing
What is your next catalyst (value inflection) update?
Multiple Ongoing
Primary Speaker
)
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}